GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...
Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...
India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...
GlaxoSmithKline ( ($GB:GSK) ) has issued an update. GSK has announced that the European Medicines Agency’s Committee for Medicinal Products for ...
St. Luke’s Medical Center Global City has established its Inhaler Clinic Service to optimize the care of patients managing pulmonary disorders such as asthma and Chronic Obstructive Pulmonary Disease ...
London: GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
The "Inhaled Drugs Contract Manufacturing Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering.
As it rolls out its US Technegas platform for detecting pulmonary embolisms, Cyclopharm is eyeing other indications including ...
Discover how poorer air quality due to smoke from Canadian wildfires in 2023 led to worsening asthma symptoms in children in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback